Vazganush Gharibyan

发表

Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees

Jia Li, J. Issa, G. Sbardella, 2011, EMBO reports.

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia.

E. Estey, J. Issa, J. Jelinek, 2005, Blood.

LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability

J. Issa, J. Jelinek, Lanlan Shen, 2007, PloS one.

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome

J. Issa, G. Malouf, Saira S Ahmed, 2016, Molecular Cancer Therapeutics.

Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate.

J. Issa, J. Jelinek, H. Kantarjian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.

E. Estey, J. Issa, Lanlan Shen, 2007, Cancer research.

Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia

J. Issa, Y. Oki, H. Kantarjian, 2007, Cancer.

DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory.

J. Issa, J. Jelinek, M. Estecio, 2012, Cancer research.

Epigenetic synergy between decitabine and platinum derivatives

Xin Hu, J. Issa, J. Jelinek, 2015, Clinical Epigenetics.

Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia

Nianxiang Zhang, J. Issa, J. Jelinek, 2011, PloS one.

Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.

S. Baylin, Ying Cui, J. Issa, 2016, Cancer Research.

Hypomethylation Dynamics Following Decitabine Therapy in Chronic Myelogenous Leukemia.

J. Issa, J. Jelinek, H. Kantarjian, 2004 .

Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.

S. Baylin, Ying Cui, J. Issa, 2016, Cancer research.

Abstract 380: Discovery of new epigenetic drugs among FDA-approved drug libraries

S. Baylin, Ying Cui, J. Issa, 2014 .